Deutscher S

No ORCID on file · 2 papers in corpus
other 2020
JAMA oncology ·doi:10.1001/jamaoncol.2020.0001

IMPORTANCE: The overall low survival rate of patients with lung cancer calls for improved detection tools to enable better treatment options and improved patient outcomes. Multivariable molecular signatures, such as blood-borne microRNA (mi…

lab-animal 2019
Diagnostics (Basel, Switzerland) ·doi:10.3390/diagnostics9040183

Ovarian cancer is often diagnosed at late stages due to current inadequate detection. Therefore, the development of new detection methods of ovarian cancer is needed. This may be achieved by phage nanoparticles that display targeting peptid…